Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis

Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis

Abstract Background The CHOICES study randomized participants with HIV and opioid use disorder (OUD) to HIV clinic-based extended-release naltrexone (XR-NTX), which requires complete cessation of opioid use, versus treatment-as-usual (i.e., buprenorphine, methadone). Study participants randomized to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kim A. Hoffman, Robin Baker, Laura C. Fanucchi, Paula J. Lum, Lynn E. Kunkel, Javier Ponce Terashima, Dennis McCarty, Petra Jacobs, P. Todd Korthuis
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Extended-release naltrexone
Opioid withdrawal
Induction
Opioid use disorder
HIV
Medicine (General)
R5-920
Social pathology. Social and public welfare. Criminology
HV1-9960
Acceso en línea:https://doaj.org/article/2f820b33cf314209a1db427de7bc6add
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/2f820b33cf314209a1db427de7bc6add

Ejemplares similares